125 results on '"Tennant, Sharon M."'
Search Results
2. Vaccine value profile for Klebsiella pneumoniae
- Author
-
Dangor, Ziyaad, Benson, Nicole, Berkley, James A., Bielicki, Julia, Bijsma, Merijn W., Broad, Jonathan, Buurman, Ed T., Cross, Alan, Duffy, Erin M., Holt, Kathryn E., Iroh Tam, Pui-Ying, Jit, Mark, Karampatsas, Konstantinos, Katwere, Michael, Kwatra, Gaurav, Laxminarayan, Ramanan, Le Doare, Kirsty, Mboizi, Robert, Micoli, Francesca, Moore, Catrin E., Nakabembe, Eve, Naylor, Nichola R., O'Brien, Seamus, Olwagen, Courtney, Reddy, Denasha, Rodrigues, Charlene, Rosen, David A., Sadarangani, Manish, Srikantiah, Padmini, Tennant, Sharon M., Hasso-Agopsowicz, Mateusz, and Madhi, Shabir A.
- Published
- 2024
- Full Text
- View/download PDF
3. Genomic diversity of non-diarrheagenic fecal Escherichia coli from children in sub-Saharan Africa and south Asia and their relatedness to diarrheagenic E. coli
- Author
-
Hazen, Tracy H., Michalski, Jane M., Tennant, Sharon M., and Rasko, David. A.
- Published
- 2023
- Full Text
- View/download PDF
4. Post-mortem investigation of deaths due to pneumonia in children aged 1–59 months in sub-Saharan Africa and South Asia from 2016 to 2022: an observational study
- Author
-
Adam, Yasmin, Agaya, Janet, Ahmed, A.S.M. Nawshad Uddin, Ahmed, Dilruba, Alemu, Addisu, Ali, Solomon, Ameh, Soter, Aol, George, Argeseanu, Solveig, Ariuman, Farida, Balogun, Oluseyi, Bari, Sanwarul, Basket, Margaret, Begum, Ferdousi, Bhandari, Manu, Blevins, John, Bunn, James, Bursuc, Courtney, Cain, Carrie Jo, Chawana, Richard, Chawla, Kiranpreet, Chukwuegbo, Cornell, Diarra, Kounandji, Diarra, Tiéman, Diaz, Maureen, Duduyemi, Babatunde, Fairchild, Karen D., Flora, Meerjady Sabrina, Fritz, Ashleigh, Garel, Mischka, Gaume, Brigitte, Gizaw, Mahlet Abayneh, Govender, Nelesh P., Greene, Carol L., Gure, Tadesse, Halu, Binyam, Hoque, Mahbubul, Hwinya, Cleopas, Ibrahim, Alexander M., Igunza, Kitiezo Aggrey, Islam, Ferdousi, Ita, Okokon, Jambai, Amara, Johnson, J. Kristie, Juma, Jane, Kaluma, Erick, Kamal, Mohammed, Kaykay, Osman, Kenneh, Sartie, Khagayi, Sammy, Koka, Rima, Kone, Diakaridia, Koplan, Jeffrey P., Kourouma, Nana, Kowuor, Dickens, LaHatte, Kristin, Lala, Sanjay G., Lee, Kyu Han, Liu, Lucy, Lombaard, Hennie, Maixenchs, Maria, Manhique, Zara, Mannah, Margaret, Martines, Roosecelis, Mash, Ronald, Mehta, Ashka, Menéndez, Clara, Misore, Thomas, Mocumbi, Sibone, Moseray, Andrew, Moses, Francis, Muga, Christopher, Munguambe, Khátia, Myburgh, Nellie, Nair, Shailesh, Ndagurwa, Pedzisai, Nhacolo, Ariel, Nhampossa, Tacilta, Nwajiobi, Princewill, Ochola, Christine, Oliech, Richard, Oluoch, Bernard, Onwuchekwa, Uma U., Onyango, Peter Nyamthimba, Orlien, Stian MS, Otieno, Peter, Oundo, Joseph, Owuor, Harun, Parveen, Shahana, Petersen, Karen, Pratt, Samuel, Rahman, Mahbubur, Rahman, Mohammad Mosiur, Rahman, Mustafizur, Raymer, Sarah, Ritter, Jana, Salzberg, Navit T., Samura, Solomon, Sannoh, Sulaiman, Sanogo, Doh, Seppeh, Martin, Sesay, Tom, Sesay, Joseph Kamanda, Shirin, Tahmina, Sissoko, Seydou, Smart, Francis, Sorour, Gillian, Squire, James, Swaray-Deen, Alim, Swart, Peter J., Tarawally, Fatmata Bintu, Tasnim, Saria, Temesgen, Fikremelekot, Tennant, Sharon M., Traore, Cheick Bougadari, Traore, Awa, Velaphi, Sithembiso, Vyas, Kurt, Wadhwa, Ashutosh, Wadula, Jeannette, Waller, Jessica, Wanga, Valentine, Warang, Shamta, Were, Joyce Akinyi, Wilson, Tais, Winchell, Jonas, Wise, Amy, Witherbee, Jakob, Yeshi, Melisachew Mulatu, Zaman, K., Mahtab, Sana, Blau, Dianna M, Madewell, Zachary J, Ogbuanu, Ikechukwu, Ojulong, Julius, Lako, Sandra, Legesse, Hailemariam, Bangura, Joseph S, Bassat, Quique, Mandomando, Inacio, Xerinda, Elisio, Fernandes, Fabiola, Varo, Rosauro, Sow, Samba O, Kotloff, Karen L, Tapia, Milagritos D, Keita, Adama Mamby, Sidibe, Diakaridia, Onyango, Dickens, Akelo, Victor, Gethi, Dickson, Verani, Jennifer R, Revathi, Gunturu, Scott, J Anthony G, Assefa, Nega, Madrid, Lola, Bizuayehu, Hiwot, Tirfe, Tseyon Tesfaye, El Arifeen, Shams, Gurley, Emily S, Islam, Kazi Munisul, Alam, Muntasir, Zahid Hossain, Mohammad, Dangor, Ziyaad, Baillie, Vicky L, Hale, Martin, Mutevedzi, Portia, Breiman, Robert F, Whitney, Cynthia G, and Madhi, Shabir A
- Published
- 2024
- Full Text
- View/download PDF
5. Provider adherence to clinical care recommendations for infants and children who died in seven low- and middle-income countries in the Child Health and Mortality Prevention Surveillance (CHAMPS) network
- Author
-
Solomon, Fatima, Sorour, Gillian, Lombaard, Hennie, Wadula, Jeannette, Petersen, Karen, Hale, Martin, Govender, Nelesh P., Swart, Peter J., Lala, Sanjay G., Velaphi, Sithembiso, Chawana, Richard, Adam, Yasmin, Wise, Amy, Fritz, Ashleigh, Myburgh, Nellie, Ndagurwa, Pedzisai, Hwinya, Cleopas, Bari, Sanwarul, Parveen, Shahana, Kamal, Mohammed, Uddin Ahmed, A.S.M. Nawshad, Hoque, Mahbubul, Tasnim, Saria, Islam, Ferdousi, Ariuman, Farida, Rahman, Mohammad Mosiur, Begum, Ferdousi, Zaman, K., Rahman, Mustafizur, Ahmed, Dilruba, Flora, Meerjady Sabrina, Shirin, Tahmina, Rahman, Mahbubur, Oundo, Joseph, Ibrahim, Alexander M., Temesgen, Fikremelekot, Gure, Tadesse, Alemu, Addisu, Yeshi, Melisachew Mulatu, Gizaw, Mahlet Abayneh, Orlien, Stian, Ali, Solomon, Otieno, Peter, Onyango, Peter Nyamthimba, Agaya, Janet, Oliech, Richard, Were, Joyce Akinyi, Gethi, Dickson, Khagayi, Sammy, Aol, George, Misore, Thomas, Owuor, Harun, Mugah, Christopher, Oluoch, Bernard, Ochola, Christine, Tennant, Sharon M., Greene, Carol L., Mehta, Ashka, Johnson, J. Kristie, Gaume, Brigitte, Koka, Rima, Fairchild, Karen D., Kone, Diakaridia, Sanogo, Doh, Onwuchekwa, Uma U., Kourouma, Nana, Sissoko, Seydou, Traore, Cheick Bougadari, Juma, Jane, Diarra, Kounandji, Traore, Awa, Diarra, Tiéman, Chawla, Kiranpreet, Nhampossa, Tacilta, Manhique, Zara, Mocumbi, Sibone, Menéndez, Clara, Munguambe, Khátia, Nhacolo, Ariel, Maixenchs, Maria, Moseray, Andrew, Tarawally, Fatmata Bintu, Seppeh, Martin, Mash, Ronald, Ojulong, Julius, Duduyemi, Babatunde, Bunn, James, Swaray-Deen, Alim, Bangura, Joseph, Jambai, Amara, Mannah, Margaret, Ita, Okokon, Chukwuegbo, Cornell, Sannoh, Sulaiman, Nwajiobi, Princewill, Kowuor, Dickens, Kaluma, Erick, Balogun, Oluseyi, Samura, Solomon, Pratt, Samuel, Moses, Francis, Sesay, Tom, Squire, James, Sesay, Joseph Kamanda, Kaykay, Osman, Halu, Binyam, Legesse, Hailemariam, Smart, Francis, Kenneh, Sartie, Ameh, Soter, Ritter, Jana, Wilson, Tais, Winchell, Jonas, Witherbee, Jakob, Salzberg, Navit T., Koplan, Jeffrey P., Basket, Margaret, Wadhwa, Ashutosh, Lee, Kyu Han, Wanga, Valentine, Martines, Roosecelis, Warang, Shamta, Diaz, Maureen, Waller, Jessica, Nair, Shailesh, Liu, Lucy, Bursuc, Courtney, LaHatte, Kristin, Raymer, Sarah, Blevins, John, Argeseanu, Solveig, Vyas, Kurt, Bhandari, Manu, Rees, Chris A., Igunza, Kitiezo Aggrey, Madewell, Zachary J., Akelo, Victor, Onyango, Dickens, El Arifeen, Shams, Gurley, Emily S., Hossain, Mohammad Zahid, Rahman, Afruna, Alam, Muntasir, Scott, J. Anthony G., Assefa, Nega, Madrid, Lola, Belachew, Anteneh, Leulseged, Haleluya, Kotloff, Karen L., Sow, Samba O., Tapia, Milagritos D., Keita, Adama Mamby, Sidibe, Diakaridia, Sitoe, Antonio, Varo, Rosauro, Ajanovic, Sara, Bassat, Quique, Mandomando, Inácio, Tippett Barr, Beth A., Ogbuanu, Ikechukwu, Cain, Carrie Jo, Bassey, Ima-Abasi, Luke, Ronita, Gassama, Khadija, Madhi, Shabir, Dangor, Ziyaad, Mahtab, Sana, du Toit, Jeanie, Mutevedzi, Portia C., Blau, Dianna M., Breiman, Robert F., and Whitney, Cynthia G.
- Published
- 2023
- Full Text
- View/download PDF
6. Neural tube defects as a cause of death among stillbirths, infants, and children younger than 5 years in sub-Saharan Africa and southeast Asia: an analysis of the CHAMPS network
- Author
-
Nawshad Uddin Ahmed, A.S.M., Hoque, Mahbubul, Kamal, Mohammed, Mosiur, Mohammad, Begum, Ferdousi, Tasnim, Saria, Flora, Meerjady Sabrina, Arjuman, Farida, Khan, Iqbal Ansary, Shirin, Tahmina, Rahman, Mahbubur, Bari, Sanwarul, Parveen, Shahana, Islam, Farzana, Hossain, Mohammad Zahid, Islam, Kazi Munisul, Ahmed, Mohammad Sabbir, Zaman, K, Rahman, Mustafizur, Ahmed, Dilruba, Chowdhury, Md Atique Iqbal, Alam, Muntasir, Lee, Kyu Han, Islam, Ferdousi, Oundo, Joseph O, Temesgen, Fikremelekot, Yeshi, Melisachew Mulatu, Ibrahim, Alexander M, Gure, Tadesse, Edris, Yunus, Alemu, Addisu, Marami, Dadi, Lemma, Ephrem, Mekonnen, Ayantu, Wale, Henok, Tesfaye, Tseyon, Leulseged, Haleluya, Dufera, Tadesse, Belachew, Anteneh, Getnet, Fentabil, Fentaw, Surafel, Acham, Yenework, Orlien, Stian MS, Abayneh Gizaw, Mahlet, Rogena, Emily, Murila, Florence, Revathi, Gunturu, Mitei, Paul K, Kuria, Magdalene, Verani, Jennifer R, Igunza, Aggrey, Nyamthimba, Peter, Oele, Elizabeth, Fairchild, Karen D, Greene, Carol L, Koka, Rima, Mehta, Ashka, Tennant, Sharon M, Johnson, J Kristie, Keita, Tatiana, Keita, Adama Mamby, Kourouma, Nana, Onwuchekwa, Uma U, Traore, Awa, Sanogo, Doh, Sidibe, Diakaridia, Sissoko, Seydou, Kone, Diakaridia, Kindcardett, Milton, Munguambe, Khátia, Nhacolo, Ariel, Nhampossa, Tacilta, Vitorino, Pio, Xerinda, Elisio, Bramugy, Justina, Monjane, Celso, Nhachungue, Sheila, Hurtado, Juan Carlos, Maixenchs, Maria, Menéndez, Clara, Ordi, Jaume, Rakislova, Natalia, Valente, Marta, Manhique, Zara, Chitungo, Dercio, Mocumbi, Sibone, Carrilho, Carla, Fernandes, Fabiola, Pass Philipsborn, Rebecca, Koplan, Jeffrey P, Garel, Mischka, Dewey, Betsy, Nair, Shailesh, Salzberg, Navit T, Liu, Lucy, Alkis-Ramirez, Rebecca, Ritter, Jana M, Zaki, Sherif R, Gary, Joy, Winchell, Jonas M, Witherbee, Jacob, Waller, Jessica L, Fayorsey, Ruby, Luke, Ronita, Bassey, Ima-Abasi, Kowuor, Dickens, Sesay, Foday, Kosia, Baindu, Pratt, Samuel, Cain, Carrie-Jo, Samura, Solomon, Solomon, Fatima, Fritz, Ashleigh, Dludlu, Noluthando, Ntuli, Constance, Chawana, Richard, Petersen, Karen, Lala, Sanjay G, Velaphi, Sithembiso, Wadula, Jeannette, Hale, Martin, Swart, Peter J, Lombaard, Hennie, Moosa, Rahima, Sorour, Gillian, Madrid, Lola, Vyas, Kartavya J, Kancherla, Vijaya, Suchdev, Parminder S, Bassat, Quique, Sow, Samba O, El Arifeen, Shams, Madhi, Shabir A, Onyango, Dickens, Ogbuanu, Ikechukwu, Scott, J Anthony G, Blau, Dianna, Mandomando, Inacio, Keita, Adama M, Gurley, Emily S, Mahtab, Sana, Akelo, Victor, Sannoh, Sulaiman, Tilahun, Yenenesh, Varo, Rosauro, Onwuchekwa, Uma, Rahman, Afruna, Adam, Yasmin, Omore, Richard, Lako, Sandra, Wise, Amy, Tippet-Barr, Beth A, Kaluma, Erick, Ajanovic, Sara, Kotloff, Karen L, Mutevedzi, Portia, Tapia, Milagritos D, Moses, Francis, Whitney, Cynthia G, and Assefa, Nega
- Published
- 2023
- Full Text
- View/download PDF
7. Pathogenomic analyses of Shigella isolates inform factors limiting shigellosis prevention and control across LMICs
- Author
-
Bengtsson, Rebecca J., Simpkin, Adam J., Pulford, Caisey V., Low, Ross, Rasko, David A., Rigden, Daniel J., Hall, Neil, Barry, Eileen M., Tennant, Sharon M., and Baker, Kate S.
- Published
- 2022
- Full Text
- View/download PDF
8. Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection
- Author
-
Nasrin, Shamima, Hegerle, Nicolas, Sen, Shaichi, Nkeze, Joseph, Sen, Sunil, Permala-Booth, Jasnehta, Choi, Myeongjin, Sinclair, James, Tapia, Milagritos D., Johnson, J. Kristie, Sow, Samba O., Thaden, Joshua T., Fowler, Jr, Vance G., Krogfelt, Karen A., Brauner, Annelie, Protonotariou, Efthymia, Christaki, Eirini, Shindo, Yuichiro, Kwa, Andrea L., Shakoor, Sadia, Singh-Moodley, Ashika, Perovic, Olga, Jacobs, Jan, Lunguya, Octavie, Simon, Raphael, Cross, Alan S., and Tennant, Sharon M.
- Published
- 2022
- Full Text
- View/download PDF
9. Safety and Tolerability of ShigActive™, a Shigella spp. Targeting Bacteriophage Preparation, in a Phase 1 Randomized, Double-Blind, Controlled Clinical Trial.
- Author
-
Chen, Wilbur H., Woolston, Joelle, Grant-Beurmann, Silvia, Robinson, Courtney K., Bansal, Garima, Nkeze, Joseph, Permala-Booth, Jasnehta, Fraser, Claire M., Tennant, Sharon M., Shriver, Mallory C., Pasetti, Marcela F., Liang, Yuanyuan, Kotloff, Karen L., Sulakvelidze, Alexander, and Schwartz, Jennifer A.
- Abstract
Bacterial diseases of the gastrointestinal (GI) tract continue to be a major worldwide cause of human morbidity and mortality. Among various enteric pathogens, Shigella spp. are some of the most common and deadly bacterial pathogens. They are responsible for ~125 million worldwide cases of shigellosis, and ~14,000 deaths annually, the majority in children under the age of 5 and occurring in developing countries. Preventing and treating shigellosis with conventional drugs (e.g., vaccines and antibiotics) has proven to be very difficult. Here, we assessed the safety and tolerability of ShigActive™, a lytic bacteriophage preparation targeting Shigella spp., in a randomized, placebo-controlled, double-blind Phase 1 clinical trial. Ten participants randomized 4:1 received ShigActive™ or placebo co-administered with sodium bicarbonate orally three times daily for 7 days. Solicited and unsolicited adverse events (AEs) were observed for 29 days. Fifty percent of the subjects receiving ShigActive™ reported mild GI-related symptoms, while one participant experienced moderate fatigue. No serious or medically attended AEs occurred through day 90. Additionally, no significant differences in GI-associated inflammatory mediators or fecal microbiome changes were observed between placebo- and ShigActive™-treated subjects, or from a participants' baseline value. The results of this first-in-human (FIH) randomized, controlled Phase 1 trial of ShigActive™ demonstrate that it is safe and well tolerated when orally administered with no significant differences compared to placebo controls. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Detecting Residual Chronic Salmonella Typhi Carriers on the Road to Typhoid Elimination in Santiago, Chile, 2017–2019.
- Author
-
Lagos, Rosanna M, Sikorski, Michael J, Hormazábal, Juan Carlos, Fernandez, Alda, Duarte, Sergio, Pasetti, Marcela F, Rasko, David A, Higginson, Ellen, Nkeze, Joseph, Kasumba, Irene N, Dougan, Gordon, Maes, Mailis, Lees, Andrew, Tennant, Sharon M, and Levine, Myron M
- Subjects
WHOLE genome sequencing ,SALMONELLA typhi ,TYPHOID fever ,SINGLE nucleotide polymorphisms ,GENOMICS - Abstract
Background In Santiago, Chile, where typhoid had been hyperendemic (1977–1991), we investigated whether residual chronic carriers could be detected among household contacts of non-travel-related typhoid cases occurring during 2017–2019. Methods Culture-confirmed cases were classified as autochthonous (domestically acquired) versus travel/immigration related. Household contacts of cases had stool cultures and serum Vi antibody measurements to detect chronic Salmonella Typhi carriers. Whole genome sequences of acute cases and their epidemiologically linked chronic carrier isolates were compared. Results Five of 16 autochthonous typhoid cases (31.3%) were linked to 4 chronic carriers in case households; 2 cases (onsets 23 months apart) were linked to the same carrier. Carriers were women aged 69–79 years with gallbladder dysfunction and Typhi fecal excretion; 3 had highly elevated serum anti-Vi titers. Genomic analyses revealed close identity (≤11 core genome single-nucleotide polymorphism [SNP] differences) between case and epidemiologically linked carrier isolates; all were genotypes prevalent in 1980s Santiago. A cluster of 4 additional autochthonous cases unlinked to a carrier was identified based on genomic identity (0-1 SNPs). Travel/immigration isolate genotypes were typical for the countries of travel/immigration. Conclusions Although autochthonous typhoid cases in Santiago are currently rare, 5 of 16 such cases (31.3%) were linked to elderly chronic carriers identified among household contacts of cases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Deletion of an immune evasion gene, steD, from a live Salmonella enterica serovar Typhimurium vaccine improves vaccine responses in aged mice.
- Author
-
Allen, Jessica C., Natta, Shanaliz S., Nasrin, Shamima, Toapanta, Franklin R., and Tennant, Sharon M.
- Subjects
SALMONELLA enterica serovar typhimurium ,VACCINE effectiveness ,ANTIBODY titer ,OLDER people ,MICE - Abstract
Introduction: Non-typhoidal Salmonella (NTS) generally causes self-limiting gastroenteritis. However, older adults (≥65 years) can experience more severe outcomes from NTS infection. We have previously shown that a live attenuated S. Typhimurium vaccine, CVD 1926 (I77 ΔguaBA ΔclpP ΔpipA ΔhtrA), was immunogenic in adult but not aged mice. Here we describe modification of CVD 1926 through deletion of steD, a Salmonella effector responsible for host immune escape, which we hypothesized would increase immunogenicity in aged mice. Methods: Mel Juso and/or mutuDC cells were infected with S. Typhimurium I77, CVD 1926, and their respective steD mutants, and the MHC-II levels were evaluated. Aged (18-month-old) C57BL/6 mice received two doses of PBS, CVD 1926, or CVD 1926 ΔsteD perorally (10
9 CFU) and the number of FliC-specific CD4+ T cells were determined. Lastly, aged C57BL/6 mice received three doses of PBS, CVD 1926, or CVD 1926 ΔsteD perorally (109 CFU) and then were challenged perorally with wild-type S. Typhimurium SL1344 (108 CFU). These animals were also evaluated for antibody responses. Results: MHC-II induction was higher in cells treated with steD mutants, compared to their respective parental strains. Compared to PBS-vaccinated mice, CVD 1926 ΔsteD elicited significantly more FliC-specific CD4+ T cells in the Peyer’s Patches. There were no significant differences in FliC-specific CD4+ T cells in the Peyer’s patches or spleen of CVD 1926- versus PBS-immunized mice. CVD 1926 and CVD 1926 ΔsteD induced similar serum and fecal anti-core and O polysaccharide antibody titers after three doses. After two immunizations, the proportion of seroconverters for CVD 1926 ΔsteD was 83% (10/12) compared to 42% (5/12) for CVD 1926. Compared to PBS-immunized mice, mice immunized with CVD 1926 ΔsteD had significantly lower S. Typhimurium counts in the spleen, cecum, and small intestine upon challenge. In contrast, there were no differences in bacterial loads in the tissues of PBS-vaccinated and CVD 1926-immunized animals. Conclusion: These data suggest that the steD deletion enhanced the immunogenicity of our live attenuated S. Typhimurium vaccine. Deletion of immune evasion genes could be a potential strategy to improve the immunogenicity of live attenuated vaccines in older adults. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
12. Initial findings from a novel population-based child mortality surveillance approach: a descriptive study
- Author
-
Acácio, Sozinho, Adam, Yasmin, Ajanovic, Sara, Alam, Muntasir, Alkis Ramirez, Rebecca, Badji, Henry, Bari, Sanwarul, Caneer, J. Patrick, Chowdhury, Atique Iqbal, Diaz, Maureen H., Fairchild, Karen D., Flora, Meerjady Sabrina, Garel, Mischka, Gibby, Adriana, Govender, Nelesh P., Greene, Carol L., Hale, Martin John, Hurtado, Juan Carlos, Johnson, J. Kristie, Kamal, Mohammed, Keita, Tatiana, Koka, Rima, Koné, Diakaridia, Lala, Sanjay G., Lombaard, Hennie, Mabunda, Rita, Martines, Roosecelis B., Mehta, Ashka, Menéndez, Clara, Mocumbi, Sibone, Moya, Claudia, Nhampossa, Tacilta, Onwuchekwa, Uma U., Parveen, Shahana, Petersen, Karen L., Phillipsborn, Rebecca Pass, Rahman, Mustafizur, Rakislova, Natalia, Ritter, Jana, Sazzad, Hossain M.S., Sidibe, Diakaridia, Sitoe, Antonio, Sivalogan, Kasthuri, Swanson, Jennifer M., Swart, Peter J., Tennant, Sharon M., Traoré, Cheick B., Varo Cobos, Rosauro, Vitorino, Pio, Valente, Marta, Velaphi, Sithembiso, Wadula, Jeannette, Waller, Jessica L., Wilkinson, Amanda L., Winchell, Jonas M., Taylor, Allan W, Blau, Dianna M, Bassat, Quique, Onyango, Dickens, Kotloff, Karen L, Arifeen, Shams El, Mandomando, Inacio, Chawana, Richard, Baillie, Vicky L, Akelo, Victor, Tapia, Milagritos D, Salzberg, Navit T, Keita, Adama Mamby, Morris, Timothy, Nair, Shailesh, Assefa, Nega, Seale, Anna C, Scott, J Anthony G, Kaiser, Reinhard, Jambai, Amara, Barr, Beth A Tippet, Gurley, Emily S, Ordi, Jaume, Zaki, Sherif R, Sow, Samba O, Islam, Farzana, Rahman, Afruna, Dowell, Scott F, Koplan, Jeffrey P, Raghunathan, Pratima L, Madhi, Shabir A, and Breiman, Robert F
- Published
- 2020
- Full Text
- View/download PDF
13. Diarrhoeal disease and subsequent risk of death in infants and children residing in low-income and middle-income countries: analysis of the GEMS case-control study and 12-month GEMS-1A follow-on study
- Author
-
Levine, Myron M, Nasrin, Dilruba, Acácio, Sozinho, Bassat, Quique, Powell, Helen, Tennant, Sharon M, Sow, Samba O, Sur, Dipika, Zaidi, Anita K M, Faruque, Abu S G, Hossain, M Jahangir, Alonso, Pedro L, Breiman, Robert F, O'Reilly, Ciara E, Mintz, Eric D, Omore, Richard, Ochieng, John B, Oundo, Joseph O, Tamboura, Boubou, Sanogo, Doh, Onwuchekwa, Uma, Manna, Byomkesh, Ramamurthy, Thandavarayan, Kanungo, Suman, Ahmed, Shahnawaz, Qureshi, Shahida, Quadri, Farheen, Hossain, Anowar, Das, Sumon K, Antonio, Martin, Saha, Debasish, Mandomando, Inacio, Blackwelder, William C, Farag, Tamer, Wu, Yukun, Houpt, Eric R, Verweiij, Jaco J, Sommerfelt, Halvor, Nataro, James P, Robins-Browne, Roy M, and Kotloff, Karen L
- Published
- 2020
- Full Text
- View/download PDF
14. Multiple Introductions of Salmonella enterica Serovar Typhi H58 with Reduced Fluoroquinolone Susceptibility into Chile
- Author
-
Maes, Mailis, Dyson, Zoe A., Higginson, Ellen E., Fernandez, Alda, Araya, Pamela, Tennant, Sharon M., Baker, Stephen, Lagos, Rosanna, Levine, Myron M., Hormazabal, Juan Carlos, and Dougan, Gordon
- Subjects
Salmonella -- Distribution -- Genetic aspects ,Microbial drug resistance -- Distribution -- Genetic aspects ,Company distribution practices ,Health - Abstract
Salmonella enterica serovars Typhi, Paratyphi A, and Paratyphi B are the etiologic agents of typhoid and paratyphoid fever. Each year, [approximately equal to] 11-21 million cases and 128,000-161,000 typhoid-related deaths [...]
- Published
- 2020
- Full Text
- View/download PDF
15. The incidence, aetiology, and adverse clinical consequences of less severe diarrhoeal episodes among infants and children residing in low-income and middle-income countries: a 12-month case-control study as a follow-on to the Global Enteric Multicenter Study (GEMS)
- Author
-
Kotloff, Karen L, Nasrin, Dilruba, Blackwelder, William C, Wu, Yukun, Farag, Tamer, Panchalingham, Sandra, Sow, Samba O, Sur, Dipika, Zaidi, Anita K M, Faruque, Abu S G, Saha, Debasish, Alonso, Pedro L, Tamboura, Boubou, Sanogo, Doh, Onwuchekwa, Uma, Manna, Byomkesh, Ramamurthy, Thandavarayan, Kanungo, Suman, Ahmed, Shahnawaz, Qureshi, Shahida, Quadri, Farheen, Hossain, Anowar, Das, Sumon K, Antonio, Martin, Hossain, M Jahangir, Mandomando, Inacio, Acácio, Sozinho, Biswas, Kousick, Tennant, Sharon M, Verweij, Jaco J, Sommerfelt, Halvor, Nataro, James P, Robins-Browne, Roy M, and Levine, Myron M
- Published
- 2019
- Full Text
- View/download PDF
16. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study
- Author
-
Liu, Jie, Platts-Mills, James A, Juma, Jane, Kabir, Furqan, Nkeze, Joseph, Okoi, Catherine, Operario, Darwin J, Uddin, Jashim, Ahmed, Shahnawaz, Alonso, Pedro L, Antonio, Martin, Becker, Stephen M, Blackwelder, William C, Breiman, Robert F, Faruque, Abu S G, Fields, Barry, Gratz, Jean, Haque, Rashidul, Hossain, Anowar, Hossain, M Jahangir, Jarju, Sheikh, Qamar, Farah, Iqbal, Najeeha Talat, Kwambana, Brenda, Mandomando, Inacio, McMurry, Timothy L, Ochieng, Caroline, Ochieng, John B, Ochieng, Melvin, Onyango, Clayton, Panchalingam, Sandra, Kalam, Adil, Aziz, Fatima, Qureshi, Shahida, Ramamurthy, Thandavarayan, Roberts, James H, Saha, Debasish, Sow, Samba O, Stroup, Suzanne E, Sur, Dipika, Tamboura, Boubou, Taniuchi, Mami, Tennant, Sharon M, Toema, Deanna, Wu, Yukun, Zaidi, Anita, Nataro, James P, Kotloff, Karen L, Levine, Myron M, and Houpt, Eric R
- Published
- 2016
- Full Text
- View/download PDF
17. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial
- Author
-
Tapia, Milagritos D, Sow, Samba O, Tamboura, Boubou, Tégueté, Ibrahima, Pasetti, Marcela F, Kodio, Mamoudou, Onwuchekwa, Uma, Tennant, Sharon M, Blackwelder, William C, Coulibaly, Flanon, Traoré, Awa, Keita, Adama Mamby, Haidara, Fadima Cheick, Diallo, Fatoumata, Doumbia, Moussa, Sanogo, Doh, DeMatt, Ellen, Schluterman, Nicholas H, Buchwald, Andrea, Kotloff, Karen L, Chen, Wilbur H, Orenstein, Evan W, Orenstein, Lauren A V, Villanueva, Julie, Bresee, Joseph, Treanor, John, and Levine, Myron M
- Published
- 2016
- Full Text
- View/download PDF
18. Status of paratyphoid fever vaccine research and development
- Author
-
Martin, Laura B., Simon, Raphael, MacLennan, Calman A., Tennant, Sharon M., Sahastrabuddhe, Sushant, and Khan, M. Imran
- Published
- 2016
- Full Text
- View/download PDF
19. Nontyphoidal salmonella disease: Current status of vaccine research and development
- Author
-
Tennant, Sharon M., MacLennan, Calman A., Simon, Raphael, Martin, Laura B., and Khan, M. Imran
- Published
- 2016
- Full Text
- View/download PDF
20. Invasive Salmonella Infections Among Children From Rural Mozambique, 2001–2014
- Author
-
Mandomando, Inácio, Bassat, Quique, Sigaúque, Betuel, Massora, Sérgio, Quintó, Llorenç, Ácacio, Sozinho, Nhampossa, Tacilta, Vubil, Delfino, Garrine, Marcelino, Macete, Eusébio, Aide, Pedro, Sacoor, Charfudin, Herrera-León, Silvia, Ruiz, Joaquim, Tennant, Sharon M., Menéndez, Clara, and Alonso, Pedro L.
- Published
- 2015
21. Invasive Nontyphoidal Salmonella Infections Among Children in Mali, 2002–2014: Microbiological and Epidemiologic Features Guide Vaccine Development
- Author
-
Tapia, Milagritos D., Tennant, Sharon M., Bornstein, Kristin, Onwuchekwa, Uma, Tamboura, Boubou, Maiga, Almoustapha, Sylla, Mamadou B., Sissoko, Seydou, Kourouma, Nana, Toure, Aliou, Malle, Dramane, Livio, Sofie, Sow, Samba O., and Levine, Myron M.
- Published
- 2015
22. Detection of Typhoidal and Paratyphoidal Salmonella in Blood by Real-time Polymerase Chain Reaction
- Author
-
Tennant, Sharon M., Toema, Deanna, Qamar, Farah, Iqbal, Najeeha, Boyd, Mary Adetinuke, Marshall, Joanna M., Blackwelder, William C., Wu, Yukun, Quadri, Farheen, Kha, Asia, Aziz, Fatima, Ahmad, Kumail, Kalam, Adil, Asif, Ehtisham, Qureshi, Shahida, Khan, Erum, Zaidi, Anita K., and Levine, Myron M.
- Published
- 2015
23. Evaluation of Three Candidate Live-Attenuated Salmonella enterica Serovar Typhimurium Vaccines to Prevent Non-Typhoidal Salmonella Infection in an Infant Mouse Model.
- Author
-
Sears, Khandra T., Nasrin, Shamima, Baliban, Scott M., Council, Danielle N., Pasetti, Marcela F., and Tennant, Sharon M.
- Subjects
SALMONELLA enterica serovar typhimurium ,SALMONELLA enterica serovar Typhi ,SALMONELLA diseases ,LABORATORY mice ,ANIMAL disease models ,FOODBORNE diseases - Abstract
Nontyphoidal Salmonella enterica (NTS) is a leading cause of foodborne illness worldwide, including in the United States, where infants show the highest incidence amongst all age groups. S. enterica serovar Typhimurium is one of the most frequently isolated serovars from NTS infections. We have developed several candidate live-attenuated S. Typhimurium vaccines to prevent NTS infection. The goal of the current study was to assess three live S. Typhimurium vaccine strains (CVD 1921, CVD 1921 ∆htrA and CVD 1926, which have two, three and four gene deletions, respectively) with various levels of reactogenicity and immunogenicity in infant BALB/c mice to predict how they would perform following peroral immunization of infants. We first tested intranasal immunization of 14-day-old mice with three doses delivered at 1-week intervals and evaluated antibody responses and protection against lethal infection with wild-type S. Typhimurium. The vaccines were administered to 14-day-old mice via the peroral route at 1- or 2-week intervals and to 28-day-old mice at 2-week intervals. The three vaccine strains were immunogenic following intranasal immunization of infant mice with vaccine efficacies of 80% (CVD 1921), 63% (CVD 1921 ∆htrA) and 31% (CVD 1926). In contrast, peroral immunization of 14-day-old mice yielded much poorer protection against lethal infection and only immunization of 28-day-old mice at 2-week intervals showed similar protective capacity as intranasal administration (CVD 1921: 83%, CVD 1921 ∆htrA: 43% and CVD 1926: 58%). CVD 1921 was consistently more protective than both CVD 1921 ∆htrA and CVD 1926, regardless of the route of vaccination, immunization schedule and age of mice. Anti-LPS serum IgG responses were similar between the three strains and did not correlate with protection. Due to previously observed reactogenicity of CVD 1921, CVD 1921 ∆htrA and CVD 1926 are our preferred vaccines, but these data show that further improvements would need to be made to achieve suitable protection in young infants when using peroral immunization. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
24. Live attenuated vaccines for invasive Salmonella infections
- Author
-
Tennant, Sharon M. and Levine, Myron M.
- Published
- 2015
- Full Text
- View/download PDF
25. Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development
- Author
-
Livio, Sofie, Strockbine, Nancy A., Panchalingam, Sandra, Tennant, Sharon M., Barry, Eileen M., Marohn, Mark E., Antonio, Martin, Hossain, Anowar, Mandomando, Inacio, Ochieng, John B., Oundo, Joseph O., Qureshi, Shahida, Ramamurthy, Thandavarayan, Tamboura, Boubou, Adegbola, Richard A., Hossain, Mohammed Jahangir, Saha, Debasish, Sen, Sunil, Faruque, Abu Syed Golam, Alonso, Pedro L., Breiman, Robert F., Zaidi, Anita K. M., Sur, Dipika, Sow, Samba O., Berkeley, Lynette Y., O'Reilly, Ciara E., Mintz, Eric D., Biswas, Kousick, Cohen, Dani, Farag, Tamer H., Nasrin, Dilruba, Wu, Yukun, Blackwelder, William C., Kotloff, Karen L., Nataro, James P., and Levine, Myron M.
- Published
- 2014
- Full Text
- View/download PDF
26. Reduced immunogenicity of a live Salmonella enterica serovar Typhimurium vaccine in aged mice.
- Author
-
Allen, Jessica C., Toapanta, Franklin R., Baliban, Scott M., Sztein, Marcelo B., and Tennant, Sharon M.
- Subjects
SALMONELLA enterica serovar typhimurium ,IMMUNE response ,SALMONELLA diseases ,FOODBORNE diseases ,VACCINE effectiveness - Abstract
Introduction: Non-typhoidal Salmonella (NTS) is responsible for a high burden of foodborne infections and deaths worldwide. In the United States, NTS infections are the leading cause of hospitalizations and deaths due to foodborne illnesses, and older adults (=65 years) are disproportionately affected by Salmonella infections. Due to this public health concern, we have developed a live attenuated vaccine, CVD 1926 (I77 DguaBA DclpP DpipA DhtrA), against Salmonella enterica serovar Typhimurium, a common serovar of NTS. Little is known about the effect of age on oral vaccine responses, and due to the decline in immune function with age, it is critical to evaluate vaccine candidates in older age groups during early product development. Methods: In this study, adult (six-to-eight-week-old) and aged (18-month-old) C57BL/6 mice received two doses of CVD 1926 (109 CFU/dose) or PBS perorally, and animals were evaluated for antibody and cell-mediated immune responses. A separate set of mice were immunized and then pre-treated with streptomycin and challenged orally with 108 CFU of wild-type S. Typhimurium SL1344 at 4 weeks postimmunization. Results: Compared to PBS-immunized mice, adult mice immunized with CVD 1926 had significantly lower S. Typhimurium counts in the spleen, liver, and small intestine upon challenge. In contrast, there were no differences in bacterial loads in the tissues of vaccinated versus PBS aged mice. Aged mice exhibited reduced Salmonella-specific antibody titers in the serum and feces following immunization with CVD 1926 compared to adult mice. In terms of T cell responses (T-CMI), immunized adult mice showed an increase in the frequency of IFN-γ- and IL-2-producing splenic CD4 T cells, IFN-γ- and TNFa-producing Peyer's Patch (PP)-derived CD4 T cells, and IFN-γ- and TNF-aproducing splenic CD8 T cells compared to adult mice administered PBS. In contrast, in aged mice, T-CMI responses were similar in vaccinated versus PBS mice. CVD 1926 elicited significantly more PP-derived multifunctional T cells in adult compared to aged mice. Conclusion: These data suggest that our candidate live attenuated S. Typhimurium vaccine, CVD 1926, may not be sufficiently protective or immunogenic in older humans and that mucosal responses to live-attenuated vaccines decrease with increasing age. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
27. Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings
- Author
-
Feasey, Nicholas A, Hadfield, James, Keddy, Karen H, Dallman, Timothy J, Jacobs, Jan, Deng, Xiangyu, Wigley, Paul, Barquist, Lars, Langridge, Gemma C, Feltwell, Theresa, Harris, Simon R, Mather, Alison E, Fookes, Maria, Aslett, Martin, Msefula, Chisomo, Kariuki, Samuel, Maclennan, Calman A, Onsare, Robert S, Weill, François-Xavier, Le Hello, Simon, Smith, Anthony M, McClelland, Michael, Desai, Prerak, Parry, Christopher M, Cheesbrough, John, French, Neil, Campos, Josefina, Chabalgoity, Jose A, Betancor, Laura, Hopkins, Katie L, Nair, Satheesh, Humphrey, Tom J, Lunguya, Octavie, Cogan, Tristan A, Tapia, Milagritos D, Sow, Samba O, Tennant, Sharon M, Bornstein, Kristin, Levine, Myron M, Lacharme-Lora, Lizeth, Everett, Dean B, Kingsley, Robert A, Parkhill, Julian, Heyderman, Robert S, Dougan, Gordon, Gordon, Melita A, and Thomson, Nicholas R
- Published
- 2016
- Full Text
- View/download PDF
28. Exploring Survey-Based Water, Sanitation, and Animal Associations With Enteric Pathogen Carriage: Comparing Results in a Cohort of Cases With Moderate-to-Severe Diarrhea to Those in Controls in the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 2015–2018
- Author
-
Berendes, David M, Omore, Richard, Prentice-Mott, Graeme, Fagerli, Kirsten, Kim, Sunkyung, Nasrin, Dilruba, Powell, Helen, Jahangir Hossain, M, Sow, Samba O, Doh, Sanogo, Jones, Joquina Chiquita M, Ochieng, John B, Juma, Jane, Awuor, Alex O, Ogwel, Billy, Verani, Jennifer R, Widdowson, Marc-Alain, Kasumba, Irene N, Tennant, Sharon M, and Roose, Anna
- Subjects
DIARRHEA prevention ,DIARRHEA ,CONFIDENCE intervals ,WATER ,SANITATION ,ECOLOGY ,SEVERITY of illness index ,FECES ,SURVEYS ,COMPARATIVE studies ,RISK assessment ,ROTAVIRUS vaccines ,DESCRIPTIVE statistics ,MICROBIOLOGICAL techniques ,RESEARCH funding ,STATISTICAL sampling ,SOCIODEMOGRAPHIC factors ,ANIMALS ,POISSON distribution ,CHILDREN - Abstract
Background: The magnitude of pediatric enteric pathogen exposures in low-income settings necessitates substantive water and sanitation interventions, including animal feces management. We assessed associations between pediatric enteric pathogen detection and survey-based water, sanitation, and animal characteristics within the Vaccine Impact on Diarrhea in Africa case-control study. Methods: In The Gambia, Kenya, and Mali, we assessed enteric pathogens in stool of children aged <5 years with moderate-to-severe diarrhea and their matched controls (diarrhea-free in prior 7 days) via the TaqMan Array Card and surveyed caregivers about household drinking water and sanitation conditions and animals living in the compound. Risk ratios (RRs) and 95% confidence intervals (CIs) were calculated using modified Poisson regression models, stratified for cases and controls and adjusted for age, sex, site, and demographics. Results: Bacterial (cases, 93%; controls, 72%), viral (63%, 56%), and protozoal (50%, 38%) pathogens were commonly detected (cycle threshold <35) in the 4840 cases and 6213 controls. In cases, unimproved sanitation (RR, 1.56; 95% CI, 1.12–2.17), as well as cows (RR, 1.61; 95% CI, 1.16–2.24) and sheep (RR, 1.48; 95% CI, 1.11–1.96) living in the compound, were associated with Shiga toxin–producing Escherichia coli. In controls, fowl (RR, 1.30; 95% CI, 1.15–1.47) were associated with Campylobacter spp. In controls, surface water sources were associated with Cryptosporidium spp., Shigella spp., heat-stable toxin-producing enterotoxigenic E. coli, and Giardia spp. Conclusions: Findings underscore the importance of enteric pathogen exposure risks from animals alongside more broadly recognized water and sanitation risk factors in children. We assessed survey-based water, sanitation, and animal factors associated with enteric pathogens in cases of moderate to severe diarrhea and controls. Animals, cows and sheep (cases) and fowl (controls), were associated with bacterial carriage; surface water was associated with bacteria and protozoa in controls. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
29. Clinical and Epidemiologic Features of Cryptosporidium-Associated Diarrheal Disease Among Young Children Living in Sub-Saharan Africa: The Vaccine Impact on Diarrhea in Africa (VIDA) Study.
- Author
-
Hossain, M Jahangir, Powell, Helen, Sow, Samba O, Omore, Richard, Roose, Anna, Jones, Joquina Chiquita M, Zaman, Syed M A, Badji, Henry, Sarwar, Golam, Kasumba, Irene N, Onwuchekwa, Uma, Doh, Sanogo, Awuor, Alex O, Ochieng, John B, Verani, Jennifer R, Liu, Jie, Tennant, Sharon M, Nasrin, Dilruba, Jamka, Leslie P, and Liang, Yuanyuan
- Subjects
DIARRHEA ,FLUID therapy ,INTRAVENOUS therapy ,CRYPTOSPORIDIOSIS ,CASE-control method ,SEASONS ,FECES ,TREATMENT effectiveness ,SEVERITY of illness index ,ROTAVIRUS vaccines ,RESEARCH funding ,HOSPITAL care ,MALNUTRITION ,POLYMERASE chain reaction ,ALGORITHMS ,NUTRITIONAL status ,SYMPTOMS ,CHILDREN - Abstract
Background: As part of the Vaccine Impact on Diarrhea in Africa (VIDA) Study, we examined the prevalence, clinical presentation, and seasonality of Cryptosporidium in children to understand its relative burden after the introduction of rotavirus vaccine. Methods: VIDA was a 3-year, age-stratified, matched case-control study of medically attended acute moderate-to-severe diarrhea (MSD) in children aged 0–59 months residing in censused populations at sites in Kenya, Mali, and The Gambia. Clinical and epidemiologic data were collected at enrollment, and a stool sample was tested for enteropathogens by quantitative PCR. An algorithm was created based on the organism's cycle threshold (Ct) and association with MSD to identify the subset of Cryptosporidium PCR-positive (Ct <35) cases most likely to be attributed to MSD. Clinical outcomes were assessed at 2–3 months after enrollment. Results: One thousand one hundred six (22.9%) cases of MSD and 873 controls (18.1%) were PCR positive for Cryptosporidium; 465 cases (42.0%) were considered attributable to Cryptosporidium, mostly among children 6–23 months. Cryptosporidium infections peaked in The Gambia and Mali during the rainy season, while in Kenya they did not have clear seasonality. Compared with cases with watery MSD who had a negative PCR for Cryptosporidium, cases with watery MSD attributed to Cryptosporidium were less frequently dehydrated but appeared more severely ill using a modified Vesikari scale (38.1% vs 27.0%; P < 0.001), likely due to higher rates of hospitalization and intravenous fluid administration, higher prevalence of being wasted or very thin very thin (23.4% vs 14.7%; P < 0.001), and having severe acute malnutrition (midupper arm circumference <115 mm, 7.7% vs 2.5%; P < 0.001). On follow-up, Cryptosporidium-attributed cases had more prolonged and persistent episodes (43.2% vs 32.7%; P <0.001) and linear growth faltering (change in height-for-age z score between enrollment and follow-up: −0.29 vs −0.17; P < 0.001). Conclusions: The burden of Cryptosporidium remains high among young children in sub-Saharan Africa. Its propensity to cause illness and further impact children longer term by compromising nutritional status early in life calls for special attention to enable appropriate management of clinical and nutritional consequences. The burden of Cryptosporidium remains high among young children in sub-Saharan Africa. Its propensity to cause illness and further impact children longer term by compromising nutritional status early in life necessitates appropriate management of clinical and nutritional consequences. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
30. Etiology, Presentation, and Risk Factors for Diarrheal Syndromes in 3 Sub-Saharan African Countries After the Introduction of Rotavirus Vaccines From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
- Author
-
Buchwald, Andrea G, Verani, Jennifer R, Keita, Adama Mamby, Jahangir Hossain, M, Roose, Anna, Sow, Samba O, Omore, Richard, Doh, Sanogo, Jones, Joquina Chiquita M, Nasrin, Dilruba, Zaman, Syed M A, Okoi, Catherine, Antonio, Martin, Ochieng, John B, Juma, Jane, Onwuchekwa, Uma, Powell, Helen, Platts-Mills, James A, Tennant, Sharon M, and Kotloff, Karen L
- Subjects
DIARRHEA ,MULTIPLE regression analysis ,RISK assessment ,COMPARATIVE studies ,ROTAVIRUS vaccines ,RESEARCH funding ,CHI-squared test ,ODDS ratio ,SYMPTOMS - Abstract
Background: Diarrheal disease is heterogeneous, including watery diarrhea (WD) and dysentery, some cases of which become persistent diarrhea (PD). Changes in risk over time necessitate updated knowledge of these syndromes in sub-Saharan Africa. Methods: The Vaccine Impact on Diarrhea in Africa (VIDA) study was an age-stratified, case-control study of moderate-to-severe diarrhea among children <5 years old in The Gambia, Mali, and Kenya (2015–2018). We analyzed cases with follow-up of about 60 days after enrollment to detect PD (lasting ≥14 days), examined the features of WD and dysentery, and examined determinants for progression to and sequelae from PD. Data were compared with those from the Global Enteric Multicenter Study (GEMS) to detect temporal changes. Etiology was assessed from stool samples using pathogen attributable fractions (AFs), and predictors were assessed using χ
2 tests or multivariate regression, where appropriate. Results: Among 4606 children with moderate-to-severe diarrhea, 3895 (84.6%) had WD and 711 (15.4%) had dysentery. PD was more frequent among infants (11.3%) than in children 12–23 months (9.9%) or 24–59 months (7.3%), P =.001 and higher in Kenya (15.5%) than in The Gambia (9.3%) or Mali (4.3%), P <.001; the frequencies were similar among children with WD (9.7%) and those with dysentery (9.4%). Compared to children not treated with antibiotics, those who received antibiotics had a lower frequency of PD overall (7.4% vs 10.1%, P =.01), and particularly among those with WD (6.3% vs 10.0%; P =.01) but not among children with dysentery (8.5% vs 11.0%; P =.27). For those with watery PD, Cryptosporidium and norovirus had the highest AFs among infants (0.16 and 0.12, respectively), while Shigella had the highest AF (0.25) in older children. The odds of PD decreased significantly over time in Mali and Kenya while increasing significantly in The Gambia. Conclusions: The burden of PD endures in sub-Saharan Africa, with nearly 10% of episodes of WD and dysentery becoming persistent. This report updates our knowledge of the risk factors and etiology associated with persistent diarrhea and dysentery. We demonstrate that both persistent and bloody diarrhea remain serious problems with distinct etiology, presentation, and outcomes among sub-Saharan African infants. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
31. Stunting Following Moderate-to-Severe Diarrhea Among Children Aged <5 Years in Africa Before and After Rotavirus Vaccine Introduction: A Comparison of the Global Enteric Multicenter Study and the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
- Author
-
Nasrin, Dilruba, Liang, Yuanyuan, Verani, Jennifer R, Powell, Helen, Sow, Samba O, Omore, Richard, Hossain, M Jahangir, Doh, Sanogo, Zaman, Syed M A, Jones, Joquina Chiquita M, Awuor, Alex O, Kasumba, Irene N, Tennant, Sharon M, Ramakrishnan, Usha, and Kotloff, Karen L
- Subjects
RESEARCH ,DIARRHEA ,CHILD nutrition ,CONFIDENCE intervals ,TIME ,CASE-control method ,VACCINE effectiveness ,COMPARATIVE studies ,ROTAVIRUS vaccines ,RESEARCH funding ,ODDS ratio ,LOGISTIC regression analysis ,GROWTH disorders ,DISEASE complications - Abstract
Background: Studies conducted before rotavirus vaccine introduction found that moderate-to-severe diarrhea (MSD) in children aged <5 years was associated with stunting at follow-up. It is unknown whether the reduction in rotavirus-associated MSD following vaccine introduction decreased the risk of stunting. Methods: The Global Enteric Multicenter Study (GEMS) and the Vaccine Impact on Diarrhea in Africa (VIDA) study, two comparable matched case-control studies, were conducted during 2007–2011 and 2015–2018, respectively. We analyzed data from 3 African sites where rotavirus vaccine was introduced after GEMS and before starting VIDA. Children with acute MSD (<7 days onset) were enrolled from a health center and children without MSD (diarrhea-free for ≥7 days) were enrolled at home within 14 days of the index MSD case. The odds of being stunted at a follow-up visit 2–3 months after enrollment for an episode of MSD was compared between GEMS and VIDA using mixed-effects logistic regression models controlling for age, sex, study site, and socioeconomic status. Results: We analyzed data from 8808 children from GEMS and 10 579 from VIDA. Among those who were not stunted at enrollment in GEMS, 8.6% with MSD and 6.4% without MSD became stunted during the follow-up period. In VIDA, 8.0% with MSD and 5.5% children without MSD developed stunting. An episode of MSD was associated with higher odds of being stunted at follow-up compared with children without MSD in both studies (adjusted odds ratio [aOR], 1.31; 95% confidence interval [CI]: 1.04–1.64 in GEMS and aOR, 1.30; 95% CI: 1.04–1.61 in VIDA). However, the magnitude of association was not significantly different between GEMS and VIDA (P =.965). Conclusions: The association of MSD with subsequent stunting among children aged <5 years in sub-Saharan Africa did not change after rotavirus vaccine introduction. Focused strategies are needed for prevention of specific diarrheal pathogens that cause childhood stunting. Despite reductions in the attributable burden of rotavirus following vaccine introduction, the association between moderate to severe diarrhea and stunting at a 2–3 month follow-up did not change between studies conducted before and after rotavirus vaccine introduction at 3 sub-Saharan African sites. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
32. Survey-Based Assessment of Water, Sanitation, and Animal-Associated Risk Factors for Moderate-to-Severe Diarrhea in the Vaccine Impact on Diarrhea in Africa (VIDA) Study: The Gambia, Mali, and Kenya, 2015–2018.
- Author
-
Berendes, David M, Fagerli, Kirsten, Kim, Sunkyung, Nasrin, Dilruba, Powell, Helen, Kasumba, Irene N, Tennant, Sharon M, Roose, Anna, Jahangir Hossain, M, Jones, Joquina Chiquita M, Zaman, Syed M A, Omore, Richard, Ochieng, John B, Verani, Jennifer R, Widdowson, Marc-Alain, Sow, Samba O, Doh, Sanogo, Sugerman, Ciara E, Mintz, Eric D, and Kotloff, Karen L
- Subjects
DIARRHEA ,CONFIDENCE intervals ,WATER ,SANITATION ,DISEASES ,SEVERITY of illness index ,LOGISTIC regression analysis ,ODDS ratio ,CHILDREN - Abstract
Background: Pediatric exposures to unsafe sources of water, unsafely managed sanitation, and animals are prevalent in low- and middle-income countries. In the Vaccine Impact on Diarrhea in Africa case-control study, we examined associations between these risk factors and moderate-to-severe diarrhea (MSD) in children <5 years old in The Gambia, Kenya, and Mali. Methods: We enrolled children <5 years old seeking care for MSD at health centers; age-, sex-, and community-matched controls were enrolled at home. Conditional logistic regression models, adjusted for a priori confounders, were used to evaluate associations between MSD and survey-based assessments of water, sanitation, and animals living in the compound. Results: From 2015 to 2018, 4840 cases and 6213 controls were enrolled. In pan-site analyses, children with drinking water sources below "safely managed" (onsite, continuously accessible sources of good water quality) had 1.5–2.0-fold higher odds of MSD (95% confidence intervals [CIs] ranging from 1.0 to 2.5), driven by rural site results (The Gambia and Kenya). In the urban site (Mali), children whose drinking water source was less available (several hours/day vs all the time) had higher odds of MSD (matched odds ratio [mOR]: 1.4, 95% CI: 1.1, 1.7). Associations between MSD and sanitation were site-specific. Goats were associated with slightly increased odds of MSD in pan-site analyses, whereas associations with cows and fowl varied by site. Conclusions: Poorer types and availability of drinking water sources were consistently associated with MSD, whereas the impacts of sanitation and household animals were context-specific. The association between MSD and access to safely managed drinking water sources post-rotavirus introduction calls for transformational changes in drinking water services to prevent acute child morbidity from MSD. We assessed water, sanitation, and animal-associated risk factors for moderate-to-severe diarrhea in children in a matched case-control study. Less availability (hours/day) and access to quality drinking water were consistent risk factors; poor sanitation and animal ownership were context-specific risk factors. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
33. Dynamics of the Gut Microbiome in Shigella-Infected Children during the First Two Years of Life.
- Author
-
Ndungo, Esther, Holm, Johanna B., Gama, Syze, Buchwald, Andrea G., Tennant, Sharon M., Laufer, Miriam K., Pasetti, Marcela F., and Rasko, David A.
- Published
- 2022
- Full Text
- View/download PDF
34. Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa
- Author
-
Okoro, Chinyere K, Kingsley, Robert A, Connor, Thomas R, Harris, Simon R, Parry, Christopher M, Al-Mashhadani, Manar N, Kariuki, Samuel, Msefula, Chisomo L, Gordon, Melita A, de Pinna, Elizabeth, Wain, John, Heyderman, Robert S, Obaro, Stephen, Alonso, Pedro L, Mandomando, Inacio, MacLennan, Calman A, Tapia, Milagritos D, Levine, Myron M, Tennant, Sharon M, Parkhill, Julian, and Dougan, Gordon
- Published
- 2012
- Full Text
- View/download PDF
35. Whole genome sequence analysis of Salmonella Typhi provides evidence of phylogenetic linkage between cases of typhoid fever in Santiago, Chile in the 1980s and 2010–2016.
- Author
-
Maes, Mailis, Sikorski, Michael J., Carey, Megan E., Higginson, Ellen E., Dyson, Zoe A., Fernandez, Alda, Araya, Pamela, Tennant, Sharon M., Baker, Stephen, Lagos, Rosanna, Hormazábal, Juan Carlos, Levine, Myron M., and Dougan, Gordon
- Subjects
TYPHOID fever ,SALMONELLA enterica serovar Typhi ,WHOLE genome sequencing ,SALMONELLA typhi ,SEQUENCE analysis ,BACTERIAL typing - Abstract
Typhoid fever epidemiology was investigated rigorously in Santiago, Chile during the 1980s, when Salmonella enterica serovar Typhi (S. Typhi) caused seasonal, hyperendemic disease. Targeted interventions reduced the annual typhoid incidence rates from 128–220 cases/10
5 population occurring between 1977–1984 to <8 cases/105 from 1992 onwards. As such, Santiago represents a contemporary example of the epidemiologic transition of an industrialized city from amplified hyperendemic typhoid fever to a period when typhoid is no longer endemic. We used whole genome sequencing (WGS) and phylogenetic analysis to compare the genotypes of S. Typhi cultured from acute cases of typhoid fever occurring in Santiago during the hyperendemic period of the 1980s (n = 74) versus the nonendemic 2010s (n = 80) when typhoid fever was rare. The genotype distribution between "historical" (1980s) isolates and "modern" (2011–2016) isolates was similar, with genotypes 3.5 and 2 comprising the majority of isolations, and 73/80 (91.3%) of modern isolates matching a genotype detected in the 1980s. Additionally, phylogenomically 'ancient' genotypes 1.1 and 1.2.1, uncommon in the global collections, were also detected in both eras, with a notable rise amongst the modern isolates. Thus, genotypes of S. Typhi causing acute illness in the modern nonendemic era match the genotypes circulating during the hyperendemic 1980s. The persistence of historical genotypes may be explained by chronic typhoid carriers originally infected during or before the 1980s. Author summary: Studies of Salmonella Typhi (the cause of typhoid fever) rarely include isolates collected both before and after the interruption of hyperendemic transmission because this typically occurred decades before modern bacteria preservation methods. After interruption, it was assumed that sporadic cases and infrequent outbreaks were due to either chronic biliary carriers or importations, but this was difficult to characterize with low resolution bacterial typing methods. In Santiago, Chile, typhoid fever persisted at hyperendemic levels through the 1980s until organized control efforts in the 1980s and changes to wastewater policy in 1991 caused annual typhoid incidence to plummet. In this study, we used whole genome sequencing (WGS) to investigate whether recent sporadic cases occurring in Santiago in the 2010s were genomically similar to S. Typhi circulating in the 1980s, or dissimilar, possibly representing importations of S. Typhi from outside of Chile. We found concordance amongst S. Typhi genotypes between the 1980s and 2010s, and differences from genotypes circulating in Southeast Asia and Africa where typhoid remains hyperendemic. Our findings suggest that a proportion of modern, rare typhoid cases in Santiago are autochthonous, and that chronic carriers or another unknown reservoir likely contribute. Broadly, our findings corroborate the epidemiologic importance of long-term reservoirs of typhoid fever decades after typhoid elimination. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
36. A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model.
- Author
-
Erdem, Rahsan, Ambler, Gwen, Al-Ibrahim, Mohamed, Fraczek, Katarzyna, Dong, Steven D., Gast, Christopher, Mercer, Laina D., Raine, Michael, Tennant, Sharon M., Chen, Wilbur H., de Hostos, Eugenio L., and Choy, Robert K. M.
- Subjects
CYSTIC fibrosis transmembrane conductance regulator ,CHOLERA ,CHOLERA vaccines ,VIBRIO infections - Abstract
Cholera remains a major cause of infectious diarrhea globally. Despite the increased availability of cholera vaccines, there is still an urgent need for other effective interventions to reduce morbidity and mortality. Furthermore, increased prevalence of antibiotic-resistant Vibrio cholerae threatens the use of many drugs commonly used to treat cholera. We developed iOWH032, a synthetic small molecule inhibitor of the cystic fibrosis transmembrane conductance regulator chloride channel, as an antisecretory, host-directed therapeutic for cholera. In the study reported here, we tested iOWH032 in a Phase 2a cholera controlled human infection model. Forty-seven subjects were experimentally infected with V. cholerae El Tor Inaba strain N16961 in an inpatient setting and randomized to receive 500 mg iOWH032 or placebo by mouth every 8 hours for 3 days to determine the safety and efficacy of the compound as a potential treatment for cholera. We found that iOWH032 was generally safe and achieved a mean (± standard deviation) plasma level of 4,270 ng/mL (±2,170) after 3 days of oral dosing. However, the median (95% confidence interval) diarrheal stool output rate for the iOWH032 group was 25.4 mL/hour (8.9, 58.3), compared to 32.6 mL/hour (15.8, 48.2) for the placebo group, a reduction of 23%, which was not statistically significant. There was also no significant decrease in diarrhea severity and number or frequency of stools associated with iOWH032 treatment. We conclude that iOWH032 does not merit future development for treatment of cholera and offer lessons learned for others developing antisecretory therapeutic candidates that seek to demonstrate proof of principle in a cholera controlled human infection model study. Trial registration: This study is registered with ClinicalTrials.gov as NCT04150250. Author summary: Cholera, a disease caused by infection with the bacterium Vibrio cholerae, remains a major cause of diarrheal illness and death, particularly in settings with poor sanitation and hygiene. We developed a synthetic chemical, named "iOWH032," as a potential treatment for cholera, which is administered as oral tablets. The chemical acts by blocking secretions from cells in the intestine, and thereby was expected to prevent fluid loss and dehydration caused by cholera illness. We tested iOWH032 in a clinical study using a cholera human challenge model. Study volunteers were intentionally infected with V. cholerae in an inpatient clinic setting to better study the effects of iOWH032 on infected individuals. This challenge model had been used previously to test cholera vaccine candidates, but this study represents the first test of a potential cholera treatment using the model. We found that treatment of individuals with iOWH032 was safe, but did not result in a significant reduction of cholera illness, based on several different measurements of diarrheal symptoms and severity. This study demonstrates how human challenge models incorporating a relatively small number of subjects can help support decision-making about potential new therapeutics and other interventions for infectious diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
37. Characterisation of atypical enteropathogenic E. coli strains of clinical origin
- Author
-
Tennant Sharon M, Tauschek Marija, Azzopardi Kristy, Bigham Andrea, Bennett-Wood Vicki, Hartland Elizabeth L, Qi Weihong, Whittam Thomas S, and Robins-Browne Roy M
- Subjects
Microbiology ,QR1-502 - Abstract
Abstract Background Enteropathogenic E. coli (EPEC) is a prominent cause of diarrhoea, and is characterised in part by its carriage of a pathogenicity island: the locus for enterocyte effacement (LEE). EPEC is divided into two subtypes according to the presence of bundle-forming pili (BFP), a fimbrial adhesin that is a virulence determinant of typical EPEC (tEPEC), but is absent from atypical EPEC (aEPEC). Because aEPEC lack BFP, their virulence has been questioned, as they may represent LEE-positive Shiga toxin-producing E. coli (STEC) that have lost the toxin-encoding prophage, or tEPEC that have lost the genes for BFP. To determine if aEPEC isolated from humans in Australia or New Zealand fall into either of these categories, we undertook phylogenetic analysis of 75 aEPEC strains, and compared them with reference strains of EPEC and STEC. We also used PCR and DNA hybridisation to determine if aEPEC carry virulence determinants that could compensate for their lack of BFP. Results The results showed that aEPEC are highly heterogeneous. Multilocus sequence typing revealed that 61 of 75 aEPEC strains did not belong to known tEPEC or STEC clades, and of those that did, none expressed an O:H serotype that is frequent in tEPEC or STEC strains associated with disease. PCR for each of 18 known virulence-associated determinants of E. coli was positive in less than 15% of strains, apart from NleB which was detected in 30%. Type I fimbriae were expressed by all aEPEC strains, and 12 strains hybridised with DNA probes prepared from either bfpA or bfpB despite being negative in the PCR for bfpA. Conclusion Our findings indicate that clinical isolates of aEPEC obtained from patients in Australia or New Zealand are not derived from tEPEC or STEC, and suggest that functional equivalents of BFP and possibly type I fimbriae may contribute to the virulence of some aEPEC strains.
- Published
- 2009
- Full Text
- View/download PDF
38. Rotavirus disease burden pre-vaccine introduction in young children in Rural Southern Mozambique, an area of high HIV prevalence.
- Author
-
Acácio, Sozinho, Nhampossa, Tacilta, Quintò, Llorenç, Vubil, Delfino, Garrine, Marcelino, Bassat, Quique, Farag, Tamer, Panchalingam, Sandra, Nataro, James P., Kotloff, Karen L., Levine, Myron M., Tennant, Sharon M., Alonso, Pedro L., and Mandomando, Inácio
- Subjects
ROTAVIRUSES ,ROTAVIRUS diseases ,RURAL children ,HIV-positive children ,ROTAVIRUS vaccines ,HAND washing ,GASTROENTERITIS ,NOROVIRUS diseases - Abstract
Background: Rotavirus vaccines have been adopted in African countries since 2009, including Mozambique (2015). Disease burden data are needed to evaluate the impact of rotavirus vaccine. We report the burden of rotavirus-associated diarrhea in Mozambique from the Global Enteric Multicenter Study (GEMS) before vaccine introduction. Methods: A case-control study (GEMS), was conducted in Manhiça district, recruiting children aged 0–59 months with moderate-to-severe diarrhea (MSD) and less-severe-diarrhea (LSD) between December 2007 and November 2012; including 1–3 matched (age, sex and neighborhood) healthy community controls. Clinical and epidemiological data and stool samples (for laboratory investigation) were collected. Association of rotavirus with MSD or LSD was determined by conditional logistic regression and adjusted attributable fractions (AF) calculated, and risk factors for rotavirus diarrhea assessed. Results: Overall 915 cases and 1,977 controls for MSD, and 431 cases and 430 controls for LSD were enrolled. Rotavirus positivity was 44% (217/495) for cases and 15% (160/1046) of controls, with AF = 34.9% (95% CI: 32.85–37.06) and adjusted Odds Ratio (aOR) of 6.4 p< 0.0001 in infants with MSD compared to 30% (46/155) in cases and 14% (22/154) in controls yielding AF = 18.7%, (95% CI: 12.02–25.39) and aOR = 2.8, p = 0.0011 in infants with LSD. The proportion of children with rotavirus was 32% (21/66) among HIV-positive children and 23% (128/566) among HIV-negative ones for MSD. Presence of animals in the compound (OR = 1.9; p = 0.0151) and giving stored water to the child (OR = 2.0, p = 0.0483) were risk factors for MSD; while animals in the compound (OR = 2.37, p = 0.007); not having routine access to water on a daily basis (OR = 1.53, p = 0.015) and washing hands before cooking (OR = 1.76, p = 0.0197) were risk factors for LSD. Conclusion: The implementation of vaccination against rotavirus may likely result in a significant reduction of rotavirus-associated diarrhea, suggesting the need for monitoring of vaccine impact. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
39. Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand
- Author
-
Robins-Browne Roy M, Tennant Sharon M, Azzopardi Kristy, Espinosa Estela M, Chinen Isabel, Miliwebsky Elizabeth S, Leotta Gerardo A, and Rivas Marta
- Subjects
Microbiology ,QR1-502 - Abstract
Abstract Background Shiga toxin-producing Escherichia coli (STEC) is an important cause of bloody diarrhoea (BD), non-bloody diarrhoea (NBD) and the haemolytic uraemic syndrome (HUS). In Argentina and New Zealand, the most prevalent STEC serotype is O157:H7, which is responsible for the majority of HUS cases. In Australia, on the other hand, STEC O157:H7 is associated with a minority of HUS cases. The main aims of this study were to compare the phenotypic and genotypic characteristics of STEC O157 strains isolated between 1993 and 1996 from humans in Argentina, Australia and New Zealand, and to establish their clonal relatedness. Results Seventy-three O157 STEC strains, isolated from HUS (n = 36), BD (n = 20), NBD (n = 10), or unspecified conditions (n = 7) in Argentina, Australia and New Zealand, were analysed. The strains were confirmed to be E. coli O157 by biochemical tests and serotyping. A multiplex polymerase chain reaction (PCR) was used to amplify the stx1, stx2 and rfbO157 genes and a genotyping method based on PCR-RFLP was used to determine stx1 and stx2 variants. This analysis revealed that the most frequent stx genotypes were stx2/stx2c (vh-a) (91%) in Argentina, stx2 (89%) in New Zealand, and stx1/stx2 (30%) in Australia. No stx1-postive strains were identified in Argentina or New Zealand. All strains harboured the eae gene and 72 strains produced enterohaemolysin (EHEC-Hly). The clonal relatedness of strains was investigated by phage typing and pulsed-field gel electrophoresis (PFGE). The most frequent phage types (PT) identified in Argentinian, Australian, and New Zealand strains were PT49 (n = 12), PT14 (n = 9), and PT2 (n = 15), respectively. Forty-six different patterns were obtained by XbaI-PFGE; 37 strains were grouped in 10 clusters and 36 strains showed unique patterns. Most clusters could be further subdivided by BlnI-PFGE. Conclusion STEC O157 strains isolated in Argentina, Australia, and New Zealand differed from each other in terms of stx-genotype and phage type. Additionally, no common PFGE patterns were found in strains isolated in the three countries. International collaborative studies of the type reported here are needed to detect and monitor potentially hypervirulent STEC clones.
- Published
- 2008
- Full Text
- View/download PDF
40. Syntheses of Salmonella Paratyphi A Associated Oligosaccharide Antigens and Development towards Anti‐Paratyphoid Fever Vaccines.
- Author
-
Dhara, Debashis, Baliban, Scott M., Huo, Chang‐Xin, Rashidijahanabad, Zahra, Sears, Khandra T., Nick, Setare Tahmasebi, Misra, Anup Kumar, Tennant, Sharon M., and Huang, Xuefei
- Subjects
SALMONELLA ,IMMUNE serums ,GLYCANS ,VACCINE development ,ANTIGENS ,ANTIBODY formation - Abstract
With the emergence of multidrug resistant Salmonella strains, the development of anti‐Salmonella vaccines is an important task. Currently there are no approved vaccines against Salmonella Paratyphi A, the leading cause of paratyphoid fever. To fill this gap, oligosaccharides corresponding to the O‐polysaccharide repeating units from the surface of Salmonella Paratyphi A have been synthesized through convergent stereoselective glycosylations. The synthetic glycan antigen was conjugated with a powerful immunogenic carrier system, the bacteriophage Qβ. The resulting construct was able to elicit strong and long‐lasting anti‐glycan IgG antibody responses, which were highly selective toward Salmonella Paratyphi A associated glycans. The availability of well‐defined glycan antigen enabled the determination that one repeating unit of the polysaccharide is sufficient to induce protective antibodies, and the paratose residue and/or the O‐acetyl modifications on the backbone are important for recognition by antibodies elicited by a Qβ‐tetrasaccharide conjugate. Immune sera provided excellent protection to mice from lethal challenge with Salmonella Paratyphi A, highlighting the potential of the synthetic glycan‐based vaccine. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
41. Surveillance for Invasive Salmonella Disease in Bamako, Mali, From 2002 to 2018.
- Author
-
Still, William L, Tapia, Milagritos D, Tennant, Sharon M, Sylla, Mamadou, Touré, Aliou, Badji, Henry, Keita, Adama Mamby, Sow, Samba O, Levine, Myron M, and Kotloff, Karen L
- Subjects
AGGLUTINATION tests ,BLOOD testing ,PEDIATRICS ,POLYMERASE chain reaction ,PUBLIC health surveillance ,SALMONELLA diseases ,DISEASE incidence ,TERTIARY care - Abstract
Background Salmonella enterica bloodstream infections are an important cause of childhood morbidity and mortality, including in Mali. We report 17 years of surveillance for nontyphoidal and typhoidal S. enterica infections among inpatients and outpatients at l'Hôpital Gabriel Touré, the main source of pediatric tertiary care in Bamako, Mali. Methods Between June 2002 and December 2018, a blood culture was collected from 54 748 children aged ≤15 years with fever and/or suspected invasive bacterial infection who provided consent (38 152 inpatients, 16 596 outpatients). Bacterial pathogens were identified using standard microbiological techniques and serovars of S. enterica were determined by PCR and/or agglutination with antisera. Results Nontyphoidal Salmonella (NTS) was identified in 671 enrolled inpatients (1.8% of all enrolled inpatients, 13.8% of enrolled inpatients with a positive culture). S. Enteritidis, the most common NTS serovar, accounted for 38.5% of all NTS isolates (n = 258), followed by S. Typhimurium (31.7%, n = 213). The median (SD) age of children with a culture positive for NTS was 1.8 (3) years. Overall case fatality was 20.9%. An additional 138 inpatients (0.4%) had a positive culture for typhoidal Salmonella. NTS was identified in 11 outpatients (0.07%), while typhoidal Salmonella was found in 49 outpatients (0.3%). The annual incidence of invasive NTS disease decreased over the study period, but case fatality remained high. Conclusions Although incidence decreased, NTS remained a major cause of invasive bacterial infection and mortality among hospitalized children in Bamako, while typhoidal Salmonella was uncommon. Because 87% of NTS belonged to only 4 serovars, a multivalent vaccine may be an effective strategy to reduce the burden and mortality of invasive NTS. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
42. Tenacious Endemic Typhoid Fever in Samoa.
- Author
-
Sikorski, Michael J, Desai, Sachin N, Tupua, Siaosi, Thomsen, Robert E, Han, Jane, Rambocus, Savitra, Nimarota-Brown, Susana, Punimata, Linatupu, Tusitala, Salesa, Sialeipata, Michelle, Hoffman, Seth A, Tracy, J Kathleen, Higginson, Ellen E, Tennant, Sharon M, Gauld, Jillian S, Klein, Daniel J, Ballard, Susan A, Robins-Browne, Roy M, Dougan, Gordon, and Nilles, Eric J
- Subjects
TYPHOID fever diagnosis ,AGE distribution ,BLOOD testing ,CENSUS ,EPIDEMICS ,MEASLES vaccines ,METROPOLITAN areas ,PUBLIC health surveillance ,SALMONELLA ,SANITATION ,TYPHOID fever ,TYPHOID vaccines ,WATER supply ,RESIDENTIAL patterns ,DISEASE incidence ,INFECTIOUS disease transmission - Abstract
Background Typhoid fever has been endemic on the island nation of Samoa (2016 population, 195 979) since the 1960s and has persisted through 2019, despite economic development and improvements in water supply and sanitation. Methods Salmonella enterica serovar Typhi isolates from the 2 hospitals with blood culture capability and matched patient demographic and clinical data from January 2008 through December 2019 were analyzed. Denominators to calculate incidence by island, region, and district came from 2011 and 2016 censuses and from 2017–2019 projections from Samoa's Bureau of Statistics. Data were analyzed to describe typhoid case burden and incidence from 2008 to 2019 by time, place, and person. Results In sum, 53–193 blood culture-confirmed typhoid cases occurred annually from 2008 to 2019, without apparent seasonality. Typhoid incidence was low among children age < 48 months (17.6–27.8/10
5 ), rose progressively in ages 5–9 years (54.0/105 ), 10–19 years (60.7–63.4/105 ), and 20–34 years (61.0–79.3/105 ), and then tapered off; 93.6% of cases occurred among Samoans < 50 years of age. Most typhoid cases and the highest incidence occurred in Northwest Upolu, but Apia Urban Area (served by treated water supplies) also exhibited moderate incidence. The proportion of cases from short-cycle versus long-cycle transmission is unknown. Samoan S. Typhi are pansusceptible to traditional first-line antibiotics. Nevertheless, enhanced surveillance in 2019 detected 4 (2.9%) deaths among 140 cases. Conclusions Typhoid has been endemic in Samoa in the period 2008–2019. Interventions, including mass vaccination with a Vi-conjugate vaccine coadministered with measles vaccine are planned. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
43. Campylobacter Abundance in Breastfed Infants and Identification of a New Species in the Global Enterics Multicenter Study.
- Author
-
Xiaoming Bian, Garber, Jolene M., Cooper, Kerry K., Steven Huynh, Jones, Jennifer, Mills, Michael K., Rafala, Daniel, Nasrin, Dilruba, Kotloff, Karen L., Parker, Craig T., Tennant, Sharon M., Miller, William G., and Szymanski, Christine M.
- Published
- 2020
- Full Text
- View/download PDF
44. Epidemiology, Risk Factors, and Outcomes of Respiratory Syncytial Virus Infections in Newborns in Bamako, Mali.
- Author
-
Buchwald, Andrea G, Tamboura, Boubou, Tennant, Sharon M, Haidara, Fadima C, Coulibaly, Flanon, Doumbia, Moussa, Diallo, Fatoumata, Keita, Adama M, Sow, Samba O, Kotloff, Karen L, Levine, Myron M, and Tapia, Milagritos D
- Subjects
AGE distribution ,FEVER ,HOSPITAL care ,INFLUENZA ,MOTHERS ,PUBLIC health surveillance ,RISK assessment ,SEX distribution ,VIRAL pneumonia ,DISEASE incidence ,PARITY (Obstetrics) ,DISEASE progression ,DESCRIPTIVE statistics ,RESPIRATORY syncytial virus infections ,DISEASE complications ,DISEASE risk factors ,CHILDREN - Abstract
Background Few studies describe the respiratory syncytial virus (RSV) burden in African populations, and most have utilized hospital-based surveillance. In Mali, no community-based studies exist of the incidence or epidemiology of RSV infection. This study provides the first estimates of RSV incidence in Mali. Methods In a cohort of infants enrolled in a clinical trial of maternal influenza vaccination, we estimate incidence of RSV-associated febrile illness in the first 6 months of life and identify risk factors for RSV infection and progression to severe disease. Infants (N = 1871) were followed from birth to 6 months of age and visited weekly to detect pneumonia and influenza-like illness. Baseline covariates were explored as risk factors for RSV febrile illness and RSV pneumonia or hospitalization. Results Incidence of RSV illness was estimated at 536.8 per 1000 person-years, and 86% (131/153) of RSV illness episodes were positive for RSV-B. RSV illness was most frequent in the fifth month of life and associated with having older mothers and with lower parity. The incidence of RSV-associated hospitalizations was 45.6 per 1000 person-years. Among infants with RSV illness, males were more likely to be hospitalized. The incidence of RSV pneumonia was 29 cases per 1000 person-years. Conclusions In the first 6 months of life, Malian infants have a high incidence of RSV illness, primarily caused by RSV-B. Prevention of early RSV will require passive protection via maternal immunization in pregnancy. Mali is the first country where RSV-B has been identified as the dominant subtype, with potential implications for vaccine development. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
45. Progress towards the development of Klebsiella vaccines.
- Author
-
Choi, Myeongjin, Tennant, Sharon M, Simon, Raphael, and Cross, Alan S
- Subjects
VACCINES ,KLEBSIELLA ,KLEBSIELLA pneumoniae ,MEMBRANE proteins ,ANTI-infective agents - Abstract
Introduction: Klebsiella pneumoniae (KP) are a leading cause of healthcare-associated infections. The dramatic increase in microbial resistance to third-generation cephalosporin and carbapenem 'front line' antimicrobial agents and the paucity of new antimicrobials have left clinicians with few therapeutic options and resulted in increased morbidity and mortality. Vaccines may reduce the incidence of infections thereby reducing the necessity for antimicrobials and are not subject to antimicrobial resistance mechanisms. Areas covered: We review whole cell, subunit, capsular polysaccharide (CPS), O polysaccharide (OPS) and conjugate vaccines against KP infection, as well as alternative KP vaccine platforms. Expert opinion: Vaccine-induced antibodies to KP CPS have been protective in preclinical studies, but the number of CPS types (>77) makes vaccines against this virulence factor less feasible. Since four OPS serotypes account of ~80% of invasive KP infections and anti-OPS antibodies are also protective in preclinical studies, both OPS-based conjugate and multiple antigen presenting system (MAPS) vaccines are in active development. Vaccines based on other KP virulence factors, such as outer membrane proteins, type 3 fimbriae (MrkA) and siderophores are at earlier stages of development. Novel strategies for the clinical testing of KP vaccines need to be developed. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
46. Genetic changes associated with the temporal shift in invasive non-typhoidal Salmonella serovars in Bamako Mali.
- Author
-
Bornstein, Kristin, Tennant, Sharon M., Hazen, Tracy H., Sorkin, John D., Tapia, Milagritos D., Sow, Samba O., Onwuchekwa, Uma, Levine, Myron M., and Rasko, David A.
- Subjects
- *
SALMONELLA , *COMPARATIVE genomics , *SEROTYPES , *BACTERIAL diseases , *COMPUTATIONAL biology , *MEDICAL microbiology - Abstract
Background: Invasive non-typhoidal Salmonella (iNTS) serovars S. Typhimurium and S. Enteritidis are major etiologic agents of invasive bacterial disease among infants and young children in sub-Saharan Africa, including in Mali. Early studies of iNTS serovars in several countries indicated that S. Typhimurium was more prevalent than S. Enteritidis, including in Mali before 2008. We investigated genomic and associated phenotypic changes associated with an increase in the relative proportion of iNTS caused by S. Enteritidis versus S. Typhimurium in Bamako, Mali, during the period 2002–2012. Methodology/Principal findings: Comparative genomics studies identified homologs of tetracycline resistance and arsenic utilization genes that were associated with the temporal shift of serovars causing iNTS shift, along with several hypothetical proteins. These findings, validated through PCR screening and phenotypic assays, provide initial steps towards characterizing the genomic changes consequent to unknown evolutionary pressures associated with the shift in serovar prevalence. Conclusions/Significance: This work identified a shift to S. Enteritidis from the more classic S. Typhimurium, associated with iNTS in Bamako, Mali, during the period 2002–2012. This type of shift in underlying iNTS pathogens are of great importance to pediatric public health in endemic regions of sub-Saharan Africa. Additionally, this work demonstrates the utility of combining epidemiologic data, whole genome sequencing, and functional characterization in the laboratory to identify and characterize genomic changes in the isolates that may be involved with the observed shift in circulating iNTS agents. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
47. Deletions in guaBA and htrA but not clpX or rfaL constitute a live-attenuated vaccine strain of Salmonella Newport to protect against serogroup C2-C3Salmonella in mice.
- Author
-
Fuche, Fabien J., Jones, Jennifer A., Ramachandran, Girish, Higginson, Ellen E., Simon, Raphael, and Tennant, Sharon M.
- Published
- 2019
- Full Text
- View/download PDF
48. Immunogenicity and protective efficacy against Salmonella C2-C3 infection in mice immunized with a glycoconjugate of S. Newport Core-O polysaccharide linked to the homologous serovar FliC protein.
- Author
-
Schuster, Ofir, Sears, Khandra T., Ramachandran, Girish, Fuche, Fabien J., Curtis, Brittany, Tennant, Sharon M., and Simon, Raphael
- Published
- 2019
- Full Text
- View/download PDF
49. Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS).
- Author
-
Vidal, Roberto M., Del Canto, Felipe, Omore, Richard, Ochieng, John B., Oundo, Joseph O., Breiman, Robert F., Mintz, Eric D., O'Reilly, Ciara E., Sommerfelt, Halvor, Robins-Browne, Roy M., Hazen, Tracy H., Rasko, David A., Muhsen, Khitam, Tennant, Sharon M., Berkeley, Lynette Y., Livio, Sofie, Panchalingam, Sandra, Nasrin, Dilruba, Farag, Tamer H., and Wu, Yukun
- Abstract
Background: Enterotoxigenic Escherichia coli (ETEC) encoding heat-stable enterotoxin (ST) alone or with heat-labile enterotoxin (LT) cause moderate-to-severe diarrhea (MSD) in developing country children. The Global Enteric Multicenter Study (GEMS) identified ETEC encoding ST among the top four enteropathogens. Since the GEMS objective was to provide evidence to guide development and implementation of enteric vaccines and other interventions to diminish diarrheal disease morbidity and mortality, we examined colonization factor (CF) prevalence among ETEC isolates from children age <5 years with MSD and from matched controls in four African and three Asian sites. We also assessed strength of association of specific CFs with MSD. Methodology/Principal findings: MSD cases enrolled at healthcare facilities over three years and matched controls were tested in a standardized manner for many enteropathogens. To identify ETEC, three E. coli colonies per child were tested by polymerase chain reaction (PCR) to detect genes encoding LT, ST; confirmed ETEC were examined by PCR for major CFs (Colonization Factor Antigen I [CFA/I] or Coli Surface [CS] antigens CS1-CS6) and minor CFs (CS7, CS12, CS13, CS14, CS17, CS18, CS19, CS20, CS21, CS30). ETEC from 806 cases had a single toxin/CF profile in three tested strains per child. Major CFs, components of multiple ETEC vaccine candidates, were detected in 66.0% of LT/ST and ST-only cases and were associated with MSD versus matched controls by conditional logistic regression (p≤0.006); major CFs detected in only 25.0% of LT-only cases weren’t associated with MSD. ETEC encoding exclusively CS14, identified among 19.9% of 291 ST-only and 1.5% of 259 LT/ST strains, were associated with MSD (p = 0.0011). No other minor CF exhibited prevalence ≥5% and significant association with MSD. Conclusions/Significance: Major CF-based efficacious ETEC vaccines could potentially prevent up to 66% of pediatric MSD cases due to ST-encoding ETEC in developing countries; adding CS14 extends coverage to ~77%. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
50. Genome and Functional Characterization of Colonization Factor Antigen I- and CS6-Encoding Heat-Stable Enterotoxin-Only Enterotoxigenic Escherichia coli Reveals Lineage and Geographic Variation.
- Author
-
Hazen, Tracy H., Nagaraj, Sushma, Sen, Sunil, Permala-Booth, Jasnehta, Del Canto, Felipe, Vidal, Roberto, Barry, Eileen M., Bitoun, Jacob P., Chen, Wilbur H., Tennant, Sharon M., and Rasko, David A.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.